Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Vivo Capital VIII, LLC | 10%+ Owner | $5.44M | Nov 21, 2023 | ||
Novo Holdings A/S | 10%+ Owner | $3.52M | Jul 13, 2022 | ||
Edgar Engleman | Director | $1.97M | Nov 29, 2023 | ||
Edith A. Perez | Chief Medical Officer | $36.5K | Mar 4, 2024 | ||
William P. Quinn | President, CEO and CFO, Director | $34.5K | Jul 23, 2024 | ||
Sarah Nemec | VP, Finance and PAO | $10.8K | Jul 23, 2024 | ||
Randall C. Schatzman | Chief Executive Officer, Director | $10.1K | Mar 4, 2024 | ||
Grant Yonehiro | Chief Operating Officer | $6.97K | Jul 23, 2024 | ||
Nicole Onetto | Director | Jun 12, 2024 | |||
David Dornan | Chief Scientific Officer | Feb 18, 2022 | |||
Brian O'callaghan | Director | Jun 12, 2024 | |||
Jakob Dupont | Director | Sep 3, 2024 | |||
Kathleen Laporte | Director | Jun 12, 2024 | |||
Laura Berner | Director | Jun 12, 2024 | |||
Frank D. Lee | Director | Jun 12, 2024 | |||
James Healy | Director | Jun 12, 2024 | |||
Richard A. Miller | Director | Jun 12, 2023 | |||
Mahendra Shah | Director | Jun 12, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|